Results 71 to 80 of about 7,666 (128)

Long-term clinical effectiveness of an acellular pertussis component vaccine and a whole cell pertussis component vaccine

open access: yes, 2002
The objective of this open study was to monitor the long-term effectiveness of the Lederle-Takeda diphtheria and tetanus toxoids and acellular pertussis antigen(s) (DTaP) vaccine and the Wyeth-Lederle diphtheria and tetanus toxoids and pertussis whole ...
Cherry, James D.   +3 more
core  

Immunogenicity and safety of co-purified diphtheria, tetanus and acellular pertussis vaccine in 6-year-old Chinese children. [PDF]

open access: yesNat Commun
Tang X   +16 more
europepmc   +1 more source

Provide the best prenatal care to prevent pertussis [PDF]

open access: yes
Strategies for healthcare professionals.Pertussis is on the rise and outbreaks are happening across the United States.In recent years, up to 1,450 infants have been hospitalized and about 10 to 20 have died each year in the United States due to pertussis.

core  

Vaccination during pregnancy and modulation of IgG response to pertussis vaccines in infants : The impact of different vaccine formulations

open access: yes
The IgG response following infant diphtheria-tetanus-acellular pertussis (DTaP) immunization is influenced by the formulation of the infant and/or the adult vaccine (Tdap) given during pregnancy.
Halperin, Scott A.   +5 more
core   +1 more source

Economic Evaluation of a New Acellular Vaccine for Pertussis in Canada

open access: yes
Objective: Pertussis is a highly contagious infection affecting mainly children. Acellular pertussis vaccines were recently introduced in Canada based on evidence of improved safety and efficacy over whole cell vaccines, the current standard of care. The
Natalie Milkovich   +7 more
core  

Home - About - Disclaimer - Privacy